When testing DNA methylation patterns as a potential contributor to variation in T2D risk across the genome, Hidalgo et al. identified a significant association of CpG methylation in two sites of the ABCG1 gene with insulin levels and IR in CD4(+) T cells from normal subjects [41]. The gene discussed is ABCG1; the disease is type 2 diabetes mellitus.